Polyelectrolytes Formulated with Primary Unconjugated Bile Acid Optimised Pharmacology of Bio-Engineered Implant.
Armin MooranianCorina Mihaela IonescuSusbin Raj WagleBožica KovacevicDaniel WalkerMelissa JonesJacqueline ChesterThomas FosterEdan JohnstonSanja P KojicGoran M StojanovićMomir MikovHani-Al SalamiPublished in: Pharmaceutics (2021)
Compared with control, the treatment group showed better survival rate, improved glycaemic control, and lower inflammatory profile, illustrated by ↓ interleukin 1-β, interleukin-6, interleukin-12, and tumour-necrosis factor-α, and ↓ levels of the bile acid, as well as lithocholic acid in the plasma, liver, large intestine and faeces. The results suggest that CDCA incorporation with PSS-PAA microcapsules exerted beneficial effects on encapsulated islets and resulted in enhanced diabetes treatment, post-transplantation, at the local and systemic levels.